CD34 and breast cancer: Several studies have addressed the hypothesis that the changes in the expression of some biological markers, such as proliferation indices, proliferating cell nuclear antigen, expression of P-gp, and epidermal growth factor receptor and CD34, might be a response to primary chemotherapy in breast cancer [7-12].